164 related articles for article (PubMed ID: 6231746)
1. Role of monoamine oxidase-B in medroxyprogesterone acetate (17-acetoxy-6 alpha-methyl-4-pregnene-3, 20-dione) induced changes in brain dopamine levels of rats.
Tandon P; Gupta ML; Barthwal JP; Gupta TK; Parmar SS; Bhargava KP
Steroids; 1983 Sep; 42(3):231-9. PubMed ID: 6231746
[TBL] [Abstract][Full Text] [Related]
2. Behavioral effects of phenelzine in an experimental model for screening anxiolytic and anti-panic drugs: correlation with changes in monoamine-oxidase activity and monoamine levels.
Griebel G; Curet O; Perrault G; Sanger DJ
Neuropharmacology; 1998 Jul; 37(7):927-35. PubMed ID: 9776388
[TBL] [Abstract][Full Text] [Related]
3. Role of catecholamines in the central actions of medroxyprogesterone acetate.
Gupta ML; Tandon P; Barthwal JP; Gupta TK; Bhargava KP
Exp Clin Endocrinol; 1983 Nov; 82(3):380-3. PubMed ID: 6228435
[TBL] [Abstract][Full Text] [Related]
4. Role of ACTH on the effect of medroxyprogesterone in brain stem serotonin.
Izquierdo JA; Savini C; Borghi E; Rabiller G; Costas S; Justel E
Pharmacol Res Commun; 1978 Jul; 10(7):643-56. PubMed ID: 213792
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of monoamine oxidase within monoaminergic neurons in the rat brain by (E)-beta-fluoromethylene-m-tyrosine (MDL 72394).
Fagervall I; Ross SB
J Neurochem; 1989 Feb; 52(2):467-71. PubMed ID: 2521360
[TBL] [Abstract][Full Text] [Related]
6. Localization of rat striatal monoamine oxidase activities towards dopamine, serotonin and kynuramine by gradient centrifugation and nigro-striatal lesions.
Van der Krogt JA; Koot-Gronsveld E; Van den Berg CJ
Life Sci; 1983 Aug; 33(7):615-23. PubMed ID: 6877035
[TBL] [Abstract][Full Text] [Related]
7. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
Aubin N; Barneoud P; Carter C; Caille D; Sontag N; Marc C; Lolivier J; Gardes A; Perron C; Le Kim A; Charieras T; Pandini M; Burnier P; Puech F; Jegham S; George P; Scatton B; Curet O
J Pharmacol Exp Ther; 2004 Sep; 310(3):1171-82. PubMed ID: 15178694
[TBL] [Abstract][Full Text] [Related]
8. The metabolism of dopamine by both forms of monoamine oxidase in the rat brain and its inhibition by cimoxatone.
Fowler CJ; Benedetti MS
J Neurochem; 1983 Jun; 40(6):1534-41. PubMed ID: 6406646
[TBL] [Abstract][Full Text] [Related]
9. Brain dialysis: in vivo metabolism of dopamine and serotonin by monoamine oxidase A but not B in the striatum of unrestrained rats.
Kato T; Dong B; Ishii K; Kinemuchi H
J Neurochem; 1986 Apr; 46(4):1277-82. PubMed ID: 2419508
[TBL] [Abstract][Full Text] [Related]
10. Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenyl.
Riederer P; Youdim MB
J Neurochem; 1986 May; 46(5):1359-65. PubMed ID: 2420928
[TBL] [Abstract][Full Text] [Related]
11. [Effect of benzamide derivatives on rat brain monoamine oxidase activity in vitro].
Gol'dina OA; Zagorevskiĭ VA; Lopatina KI; Sokolova TV; Gankina EM
Biull Eksp Biol Med; 1986 Aug; 102(8):170-2. PubMed ID: 3742029
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of cis- and trans-resveratrol on noradrenaline and 5-hydroxytryptamine uptake and on monoamine oxidase activity.
Yáñez M; Fraiz N; Cano E; Orallo F
Biochem Biophys Res Commun; 2006 Jun; 344(2):688-95. PubMed ID: 16631124
[TBL] [Abstract][Full Text] [Related]
13. [Distinctions in metabolism of serotonin and dopamine in rat brain during latent inhibition].
Molodtsova GF
Zh Vyssh Nerv Deiat Im I P Pavlova; 2002; 52(1):71-7. PubMed ID: 11899670
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of monoamine oxidase A or B reduces striatal oxidative stress in rats with partial depletion of the nigro-striatal dopaminergic pathway.
Aluf Y; Vaya J; Khatib S; Loboda Y; Finberg JP
Neuropharmacology; 2013 Feb; 65():48-57. PubMed ID: 22982254
[TBL] [Abstract][Full Text] [Related]
15. Specificity of endogenous substrates for types A and B monoamine oxidase in rat striatum.
Schoepp DD; Azzaro AJ
J Neurochem; 1981 Jun; 36(6):2025-31. PubMed ID: 6787175
[TBL] [Abstract][Full Text] [Related]
16. [Changes induced by ethanol in monoamine oxidase activity in the rat's brain mitochondria: MAO-DA and MAO-NA].
Renis M; Giovine A; Bertolino A
Acta Neurol (Napoli); 1974; 29(3):293-8. PubMed ID: 4422384
[No Abstract] [Full Text] [Related]
17. The ex vivo effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on rat intra- and extraneuronal monoamine oxidase activity.
Arai Y; Toyoshima Y; Kinemuchi H; Tadano T; Kisara K
Neurosci Lett; 1986 Oct; 70(2):266-71. PubMed ID: 3490638
[TBL] [Abstract][Full Text] [Related]
18. Circadian variations in the monoamine levels and monoamine oxidase activity in different regions of the rat brain as a function of age.
Bhaskaran D; Radha E
Exp Gerontol; 1984; 19(3):153-70. PubMed ID: 6479252
[TBL] [Abstract][Full Text] [Related]
19. A and B forms of monoamine oxidase within the monoaminergic neurons of the rat brain.
Fagervall I; Ross SB
J Neurochem; 1986 Aug; 47(2):569-76. PubMed ID: 3734795
[TBL] [Abstract][Full Text] [Related]
20. [Changes in brain monoamine oxidase activity in conditioned passive avoidance reaction in rats].
Molodtsova GF
Biull Eksp Biol Med; 1992 Apr; 113(4):342-4. PubMed ID: 1391882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
